HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION (ABMT) AS CONSOLIDATION THERAPY DURING FIRST CR PR IN PATIENTS WITH POOR-RISK INTERMEDIATE-AND HIGH-GRADE LYMPHOMA/
A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION (ABMT) AS CONSOLIDATION THERAPY DURING FIRST CR PR IN PATIENTS WITH POOR-RISK INTERMEDIATE-AND HIGH-GRADE LYMPHOMA/, Blood, 88(10), 1996, pp. 2725-2725